脑药物转运载体——抗转铁蛋白受体单链抗体的克隆表达及鉴定

为构建特异性的脑药物转运载体 ,分段合成了抗大鼠转铁蛋白受体的单链抗体基因 (Ox2 6 scfv) .经重叠PCR拼接成完整片段 ,克隆入pUC19载体中 ,测序正确后克隆到大肠杆菌表达载体pET 15b E .tag上 .IPTG诱导 ,表达产物分子量为 2 9kD ,约占菌体总蛋白量的 4 0 % .包涵体经 6mol L盐酸胍变性后 ,过SephacrylS 30 0HR分子筛柱复性蛋白 .免疫酶染色实验表明 ,该单链抗体能与转铁蛋白受体特异性结合 ,为建立以转铁蛋白受体为介导的血脑屏障转运载体打下了基础     

抗转铁蛋白受体单链抗体的表达、纯化及活性测定

根据转铁蛋白受体和转铁蛋白特异性结合的性质,利用亲和纯化的方法从胎盘中提取转铁蛋白受体。以转铁蛋白受体为抗原包被免疫管,从全合成人源噬菌体单链抗体库中筛选其抗体。对筛选到的抗体进行特异性鉴定后,将抗体基因插入表达载体pET22b( ),转化大肠杆菌BL21(DE3),IPTG诱导后获得可溶性表达。HeLa细胞的免疫组化结果显示,表达的抗体可以与转铁蛋白受体结合。表达产物经Ni-NTA金属螯和层析柱纯化、脱咪唑后,从尾静脉注射小鼠。1h后,去除血液及毛细血管的干扰,在脑实质中检测到了抗体的存在,说明该抗体可以通过血脑屏障。     

转铁蛋白受体单链抗体与链亲和素融合基因的克隆及其在大肠杆菌中的可溶性表达

目的:转铁蛋白受体特异性富含于血脑屏障和肿瘤细胞的表面,是当前中枢神经系统疾病和肿瘤治疗中定向转运的重要靶标。拟获得在大肠杆菌中能高效可溶表达的转铁蛋白受体单链抗体与链亲和素(SA)的重组融合蛋白。方法:根据GenBank数据库报道的SA的核苷酸序列分段合成基因,连接后经PCR获得完整的基因片段,插入pGEM-T载体中测序。将序列正确的SA基因与大鼠转铁蛋白受体单链抗体基因ox26-scFv分别插入原核表达载体pTIG-Trx中,构建重组表达克隆pTIG-Trx/scFv-SA,并在大肠杆菌中诱导表达。ELISA检测融合蛋白的生物学活性。结果:对pGEM-T/SA克隆的测序结果显示,合成的SA基因与文献报道相符。重组融合蛋白在大肠杆菌中获得了可溶性表达,约占菌体上清总蛋白量的30%;ELISA结果表明该融合蛋白具备与转铁蛋白受体和生物素的结合的双重活性。结论:有活性的重组融合蛋白的获得为构建一个通用性的以转铁蛋白受体介导的血脑屏障和肿瘤转运靶向载体打下了基础。     

转铁蛋白受体单链抗体与BDNF融合蛋白的表达及活性鉴定

脑源性神经营养因子（BDNF）对中枢神经系统的多种神经元具有营养,修复和保护功能,但因无法通过血脑屏障限制了其应用。本文利用抗转铁蛋白受体（TfR）的单链抗体（ox26-scFv）作为脑转运载体,分别扩增单链抗体和BDNF基因,插入pTIG-Trx载体,构建融合基因表达载体pTIG-Trx/scFv-BDNF,在大肠杆菌BL21（DE3）中实现了高效表达。经Ni-NTA金属鏊合层析柱纯化后,在41Kd处可见目的纯化条带。大鼠GH3细胞免疫酶染色显示,ScFv-BDNF融合蛋白能与转铁蛋白受体特异性结合。同时能够促进鸡胚背根节神经突起的生长,具备了BDNF的生物学活性。为使BDNF能够跨越血脑屏障成为中枢神经系统的治疗药物打下了实验基础。     

大鼠转铁蛋白受体单链抗体和芋螺毒素SO3的融合蛋白在大肠杆菌中的表达

人工合成了芋螺毒素SO3的基因片段,通过链延伸方法获得了SO3的全长基因。在此基础上,将SO3基因插入到含抗大鼠转铁蛋白受体的单链抗体基因的pTIG-Trx表达载体中,构建含抗大鼠转铁蛋白受体单链抗体和SO3融合基因的重组表达载体,转化大肠杆菌BL21(DE3)和Origmia(DE3)／DsbC并得到了表达,该融合蛋白主要以包涵体形式存在。为进一步研究芋螺毒素SO3跨血脑屏障转运和治疗作用奠定了基础。     

人转铁蛋白受体及其特异性抗体的制备

目的:从胎盘中提取转铁蛋白受体并获得抗转铁蛋白受体的抗体。方法:人新鲜胎盘组织被破碎后,用去污剂TritonX-100裂解细胞膜,释放膜蛋白。利用膜蛋白中的转铁蛋白受体能与铁-转铁蛋白复合物特异性结合的特性对其进行亲和纯化。对纯化得到的目的蛋白,经脱盐后进行ELISA及肽质量图谱分析,证明为所需的转铁蛋白受体后,以其包被免疫管,从全合成人源噬菌体抗体库中筛选抗体。结果:从人源噬菌体抗体库中筛选到5个能够与转铁蛋白受体特异性结合的噬菌体单链抗体。结论:以人源转铁蛋白受体为抗体,可从全人源噬菌体抗体库中筛选到其特异性的抗体。     

抗人黑色素瘤单链抗体基因在大肠杆菌中的融合表达

应用RT-PCR技术从分泌抗人黑色素瘤单克隆抗体的杂交瘤细胞HB8760中克隆了抗体轻、重链可变区基因,用(Gly₄Ser)₃连接肽基因将V_H、V_L连接成ScFv基因,并进行了序列测定。ScFv基因全长927bp,其中VH基因长360bp,编码120个氨基酸,V_L基因长324bp,编码108个氨基酸。在大肠杆菌融合表达载体pGEX-4T-1中表达了GST-ScFv融合蛋白,表达产量占菌体总蛋白的29%。凝血酶消化后的产物具有黑色素瘤细胞结合活性。     

抗HBsAg人源单链可变区抗体的筛选与可溶性抗体的表达

采用噬菌体表达展示技术,以从乙型肝炎病毒（HBV）表达抗原（HBsAg）阳性血汪有超速离心纯化的HBsAg为固相抗原,从噬菌体单链可变区半合成抗体库中经过5轮“吸附－洗脱－扩增”筛选过程,获得特异性较强的HBsAg人源单链可变区抗体（ScFv）克隆并提取质粒,经SfiⅠ/NotⅠ酶切鉴定后,亚克隆到pCANTAB5E表达载体中,转化大肠杆菌XL1－Blue。经IPTG诱导后,表达的可溶性HBsAg特异性ScFv以50％硫酸胺沉淀,经SDS－PAGE电泳表明,XL1－Blue中表达的HBsAg可溶性ScFv的分子量约28kD。免疫活性检测结果表明,该单链抗体具有较强的抗原结合性和特异性。HBsAg人源单链抗体的筛选和表达成功,为今后HBsAg人源抗体的研究和应用奠定了基础。     

抗HBsAg人源单链可变区抗体的筛选与可溶性抗体的表达

采用噬菌体表面展示技术,以从乙型肝炎病毒(HBV)表面抗原(HBsAg)阳性血清超速离心纯化的HBsAg为固相抗原,从噬菌体单链可变区半合成抗体库中经过5轮“吸附-洗脱-扩增”筛选过程,获得特异性较强的HBsAg人源单链可变区抗体(ScFv)克隆并提取质粒,经SfiⅠ/NotⅠ酶切鉴定后,亚克隆到pCANTAB5E表达载体中,转化大肠杆菌XL1-Blue。经IPTG诱导后,表达的可溶性HBsAg特异性ScFv以50%硫酸胺沉淀,经SDS-PAGE电泳表明,XL1-Blue中表达的HBsAg可溶性ScFv的分子量约28?kD。免疫活性检测结果表明,该单链抗体具有较强的抗原结合活性和特异性。HBsAg人源单链抗体的筛选和表达成功,为今后HBsAg人源抗体的研究和应用奠定了基础。     

Expression of anti human IL-4 and IL-6 scFvs in transgenic tobacco plants

The two murine single-chain Fv (scFv) genes against human interleukin IL-4 and IL-6 cytokines were cloned in a plant expression vector (pGEJAE1) and mobilized to Agrobacterium tumefaciens. Tobacco leaf discs were co-cultured with Agrobacterium and transferred to selective media for regeneration. The tobacco in vitro plants produced scFvs against human IL-4 and IL-6. Only 8% of transformed plants expressing anti-IL-4 scFv were obtained versus 76% of transformed plants expressing anti-IL-6 scFv. In addition, some plants producing anti-IL-4 and anti-IL-6 scFvs aged more rapidly in in vitro conditions and in greenhouse pots than did control plants. Western blot analysis showed that the transformed Nicotiana tabacum plants contained proteins with an apparent molecular mass on electrophoresis of ca. 32 kDa, corresponding to the predicted size of the scFvs. As entire plant root seemed to accumulate more scFv than did leaves, we decided to continue working with isolated roots. Anti-IL-6 scFvs were detected in cultivated roots and their culture media. Functional anti-IL-6 scFv accounted for 0.16–0.18% of total soluble proteins. The affinity of the anti-IL-6 scFv produced in plants and measured by Biacore was similar to that of scFv produced in Escherichia coli. The high levels of antibody accumulation in isolated roots and secretion into the medium demonstrate the potential for producing recombinant protein in bioreactor systems.these authors contributed equally to this workthese authors contributed equally to this work     

人源抗破伤风毒素单链抗体(ScFv)的原核表达、纯化及功能鉴定

实验通过DNA重组技术从一株可中和破伤风毒素的人源单克隆抗体细胞(G6)中扩增出了抗体VH、VL的基因,通过重叠PCR使连接片段与VH、VL连接成单链ScFv。经测序证实VH、VL为抗体的可变区序列,命名为ScFv-G6。将ScFv-G6连接转化PET/26b质粒,构建了抗体的表达载体,被命名为PET/26b/ScFv-G6。以该载体在大肠杆菌中分泌表达产物经Ni-亲和柱纯化后的小鼠试验证实,可抵抗破伤风毒素的攻击,表明为中和抗体。具有组织穿透力强,不易过敏,可直接靶向于毒素等特点,适合于破伤风的防治,具有重要的应用价值。     

Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures

A synthetic gene encoding an anti-phytochrome single-chain Fv (scFv) antibody bearing an N-terminal signal peptide has been used to transform tobacco plants. Immunoblot analysis showed that transformed plants accumulate high levels of scFv protein, accounting for up to 0.5% of the total soluble protein fraction, which could be extracted by simple infiltration and centrifugation of leaf tissue. A substantial proportion of the scFv protein extracted in this way was found to possess antigen-binding activity. Callus cell suspension cultures derived from transformed plants secrete functional scFv protein into the surrounding medium. Compared with the levels of scFv protein observed in plants expressing the native scFv gene, the incorporation of an N-terminal signal peptide, to target the scFv to the apoplast, results in elevated accumulation of the protein.     

Combination of Dsb coexpression and an addition of sorbitol markedly enhanced soluble expression of single-chain Fv in Escherichia coli

Many eukaryotic proteins have been produced successfully in Escherichia coli. However, not every gene can be expressed efficiently in this organism. Most proteins, especially those with multiple disulfide bonds, have been shown to form insoluble protein or inclusion body in E. coli. An inactive form of protein would require an in vitro refolding step to regain biological functions. In this study, we described the system for soluble expression of a single-chain variable fragment (scFv) against hepatocellular carcinoma (Hep27scFv) by coexpressing Dsb protein and enhancing with medium additives. The results revealed that overexpression of DsbABCD protein showed marked effect on the soluble production of Hep27scFv, presumably facilitating correct folding. The optimal condition for soluble scFv expression could be obtained by adding 0.5M sorbitol to the culture medium. The competitive enzyme-linked immunosorbent assay (ELISA) indicated that soluble scFv expressed by our method retains binding activity toward the same epitope on a hepatocellular carcinoma cell line (HCC-S102) recognized by intact antibody (Ab) (Hep27 Mab). Here, we report an effective method for soluble expression of scFv in E. coli by the Dsb coexpression system with the addition of sorbitol medium additive. This method might be applicable for high-yield soluble expression of proteins with multiple disulfide bonds.